TMZ, Temozolomide, RNASynthesis, RNA Synthesis, TZM, Autophagy, Apoptosis, CCRG 81045, CCRG81045, CCRG-81045, DNASynthesis, DNA Synthesis, DNAAlkylator, DNA replication, DNA Alkylator, DNA Alkylator/Crosslinker, Crosslinker, NSC362856, NSC-362856, inhibit, NSC 362856, Inhibitor
Temozolomide is an orally bioavailable DNA alkylating agent capable of crossing the blood-brain barrier. It exhibits antitumor, antiangiogenic, and pro-apoptotic properties and is widely used in glioblastoma research, both in vitro and in vivo, due to its stability in acidic conditions and hydrolysis at neutral to basic pH.
Molecular Weight:
194.15
Purity:
99.87% (May vary between batches)
CAS Number:
[85622-93-1]
Formula:
C6H6N6O2
Target:
DNA Alkylator/Crosslinker,Apoptosis,Autophagy,DNA/RNA Synthesis
